UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029705
Receipt number R000033948
Scientific Title Ramdomized-controlled trial of oral exercise for obstructive sleep apnea syndrome patient who have lower lingual pressure
Date of disclosure of the study information 2022/11/30
Last modified on 2017/10/25 13:20:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Ramdomized-controlled trial of oral exercise
for obstructive sleep apnea syndrome patient who have lower lingual pressure

Acronym

Ramdomized-controlled trial of oral exercise
for obstructive sleep apnea syndrome patient who have lower lingual pressure

Scientific Title

Ramdomized-controlled trial of oral exercise
for obstructive sleep apnea syndrome patient who have lower lingual pressure

Scientific Title:Acronym

Ramdomized-controlled trial of oral exercise
for obstructive sleep apnea syndrome patient who have lower lingual pressure

Region

Japan


Condition

Condition

obstructive sleep apnea

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the effectiveness of two types of oral exercise in the treatment of OSAS and their impact on the reduction of AHI(Apnea Hypopnea Index).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

AHI(Apnea Hypopnea Index) after 12weeks from the beginning of treatment

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment Other

Interventions/Control_1

Doing standard oral exercise 30 minitues per day for 12weeks

Interventions/Control_2

Doing oral exercise using tongue training machine 30 minitues per day for 12weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)Patients who is over 20-years-old when wrote informed consent
(2)AHI>5
(3)Patients from whom written informed consent is obtained in this study
(4)Patients whose tongue pressure was lower than 30kPa

Key exclusion criteria

(1)Patients who have severe cardiac disorder
(2)Patients who have dementia
(3)Patients who have severe neuromuscular disorder
(4)Patients who thought to be inadequate

Target sample size

45


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tatsuya Nagano

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratory Medicine, Department of Internal Medicine,

Zip code


Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan

TEL

078-382-5660

Email

tnagano@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Reina Sekiya

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratory Medicine, Department of Internal Medicine,

Zip code


Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan

TEL

078-382-5660

Homepage URL


Email

reina.aoyama@gmail.com


Sponsor or person

Institute

Division of Respiratory Medicine, Department of Internal Medicine,Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 11 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2017 Year 10 Month 25 Day

Date of IRB


Anticipated trial start date

2017 Year 11 Month 30 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 10 Month 25 Day

Last modified on

2017 Year 10 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033948